[
  {
    "ts": null,
    "headline": "West Pharmaceutical Services Inc. stock underperforms Thursday when compared to competitors",
    "summary": "West Pharmaceutical Services Inc. stock underperforms Thursday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=d4787962d672f0fae9b0ed637ad199236df6b1981f68f85e067f28353a6a7b7c",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745514600,
      "headline": "West Pharmaceutical Services Inc. stock underperforms Thursday when compared to competitors",
      "id": 134087324,
      "image": "",
      "related": "WST",
      "source": "MarketWatch",
      "summary": "West Pharmaceutical Services Inc. stock underperforms Thursday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=d4787962d672f0fae9b0ed637ad199236df6b1981f68f85e067f28353a6a7b7c"
    }
  },
  {
    "ts": null,
    "headline": "West Pharmaceutical Services, Inc. (WST) Q1 2025 Earnings Call Transcript",
    "summary": "West Pharmaceutical Services, Inc. (NYSE:WST) Q1 2025 Earnings Conference Call April 24, 2025 9:00 AM ETCompany ParticipantsJohn Sweeney - Vice President of...",
    "url": "https://finnhub.io/api/news?id=f8ff8ea2eb688b3c1112f9b8a0281c109f97f8155f5984a221041bd9f079196c",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745509935,
      "headline": "West Pharmaceutical Services, Inc. (WST) Q1 2025 Earnings Call Transcript",
      "id": 134064073,
      "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
      "related": "WST",
      "source": "SeekingAlpha",
      "summary": "West Pharmaceutical Services, Inc. (NYSE:WST) Q1 2025 Earnings Conference Call April 24, 2025 9:00 AM ETCompany ParticipantsJohn Sweeney - Vice President of...",
      "url": "https://finnhub.io/api/news?id=f8ff8ea2eb688b3c1112f9b8a0281c109f97f8155f5984a221041bd9f079196c"
    }
  },
  {
    "ts": null,
    "headline": "WST Stock Rises on Q1 Earnings Beat, EPS View Up on Tariff & FX Benefit",
    "summary": "West Pharmaceutical's first-quarter top line continues to benefit from revenue growth in its Proprietary Products segment.",
    "url": "https://finnhub.io/api/news?id=3ff9d8b61059503a8b3e60bb1162d24ae7bef64972282df649e7095e1b7afc32",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745508960,
      "headline": "WST Stock Rises on Q1 Earnings Beat, EPS View Up on Tariff & FX Benefit",
      "id": 134068372,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "WST",
      "source": "Yahoo",
      "summary": "West Pharmaceutical's first-quarter top line continues to benefit from revenue growth in its Proprietary Products segment.",
      "url": "https://finnhub.io/api/news?id=3ff9d8b61059503a8b3e60bb1162d24ae7bef64972282df649e7095e1b7afc32"
    }
  },
  {
    "ts": null,
    "headline": "West Pharmaceutical Services, Inc. 2025 Q1 - Results - Earnings Call Presentation",
    "summary": "The following slide deck was published by West Pharmaceutical Services, Inc.",
    "url": "https://finnhub.io/api/news?id=db15e34a512c868d53df3363ba4f1a148753df0ec4a2227a77150f2135443f88",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745504405,
      "headline": "West Pharmaceutical Services, Inc. 2025 Q1 - Results - Earnings Call Presentation",
      "id": 134063600,
      "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
      "related": "WST",
      "source": "SeekingAlpha",
      "summary": "The following slide deck was published by West Pharmaceutical Services, Inc.",
      "url": "https://finnhub.io/api/news?id=db15e34a512c868d53df3363ba4f1a148753df0ec4a2227a77150f2135443f88"
    }
  },
  {
    "ts": null,
    "headline": "West Pharma raises profit forecast as dollar weakens amid Trump's tariff policies",
    "summary": "The Pennsylvania-based company said it expected a $20 million to $25 million hit from Trump's shifting trade policies.  \"We are closely monitoring potential impacts, both political and macroeconomic, in order to react as quickly as possible with offsetting mitigating measures,\" said West's CEO Eric Green.  The medical equipment maker raised its annual sales forecast to between $2.95 billion and $2.98 billion, from $2.88 billion to $2.91 billion previously.",
    "url": "https://finnhub.io/api/news?id=49956e8ede8d497c1268ed75b01d9100ab84777b95acd0ef99a9b78107500d56",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745493166,
      "headline": "West Pharma raises profit forecast as dollar weakens amid Trump's tariff policies",
      "id": 134060039,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "WST",
      "source": "Yahoo",
      "summary": "The Pennsylvania-based company said it expected a $20 million to $25 million hit from Trump's shifting trade policies.  \"We are closely monitoring potential impacts, both political and macroeconomic, in order to react as quickly as possible with offsetting mitigating measures,\" said West's CEO Eric Green.  The medical equipment maker raised its annual sales forecast to between $2.95 billion and $2.98 billion, from $2.88 billion to $2.91 billion previously.",
      "url": "https://finnhub.io/api/news?id=49956e8ede8d497c1268ed75b01d9100ab84777b95acd0ef99a9b78107500d56"
    }
  },
  {
    "ts": null,
    "headline": "West Pharmaceutical Services (WST) Q1 Earnings and Revenues Beat Estimates",
    "summary": "West Pharmaceutical (WST) delivered earnings and revenue surprises of 18.85% and 1.68%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?",
    "url": "https://finnhub.io/api/news?id=fc56dac0bf17e56465550d333469d420b6d4547ae04a9a6cf80e4140ef034158",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745493008,
      "headline": "West Pharmaceutical Services (WST) Q1 Earnings and Revenues Beat Estimates",
      "id": 134060040,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "WST",
      "source": "Yahoo",
      "summary": "West Pharmaceutical (WST) delivered earnings and revenue surprises of 18.85% and 1.68%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?",
      "url": "https://finnhub.io/api/news?id=fc56dac0bf17e56465550d333469d420b6d4547ae04a9a6cf80e4140ef034158"
    }
  },
  {
    "ts": null,
    "headline": "West Pharmaceutical Q1 Adjusted Earnings Decline, Sales Increase; 2025 Outlook Lifted",
    "summary": "West Pharmaceutical Services (WST) reported Q1 adjusted earnings Thursday of $1.45 per diluted share",
    "url": "https://finnhub.io/api/news?id=c14452d30aa7eef4d2a2c258fb5a836a44f20cfc020f7f7150b8a7b0b2de67aa",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745491404,
      "headline": "West Pharmaceutical Q1 Adjusted Earnings Decline, Sales Increase; 2025 Outlook Lifted",
      "id": 134060041,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "WST",
      "source": "Yahoo",
      "summary": "West Pharmaceutical Services (WST) reported Q1 adjusted earnings Thursday of $1.45 per diluted share",
      "url": "https://finnhub.io/api/news?id=c14452d30aa7eef4d2a2c258fb5a836a44f20cfc020f7f7150b8a7b0b2de67aa"
    }
  },
  {
    "ts": null,
    "headline": "West Announces Leadership Changes",
    "summary": "West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced executive leadership changes as part of its succession planning process.",
    "url": "https://finnhub.io/api/news?id=84118ac073b09ed5279714954da2deddcc4b003eaa5a79cbcfa3ee9f81cd972c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745489400,
      "headline": "West Announces Leadership Changes",
      "id": 134060042,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "WST",
      "source": "Yahoo",
      "summary": "West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced executive leadership changes as part of its succession planning process.",
      "url": "https://finnhub.io/api/news?id=84118ac073b09ed5279714954da2deddcc4b003eaa5a79cbcfa3ee9f81cd972c"
    }
  },
  {
    "ts": null,
    "headline": "West Pharmaceutical: Q1 Earnings Snapshot",
    "summary": "WST) on Thursday reported first-quarter profit of $89.8 million. On a per-share basis, the Exton, Pennsylvania-based company said it had profit of $1.23. Earnings, adjusted for restructuring costs and amortization costs, were $1.45 per share.",
    "url": "https://finnhub.io/api/news?id=a7009a5fe6b7bff172077454f13232689b10c326535dd16bdd85efc8ead48c24",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745489356,
      "headline": "West Pharmaceutical: Q1 Earnings Snapshot",
      "id": 134060043,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "WST",
      "source": "Yahoo",
      "summary": "WST) on Thursday reported first-quarter profit of $89.8 million. On a per-share basis, the Exton, Pennsylvania-based company said it had profit of $1.23. Earnings, adjusted for restructuring costs and amortization costs, were $1.45 per share.",
      "url": "https://finnhub.io/api/news?id=a7009a5fe6b7bff172077454f13232689b10c326535dd16bdd85efc8ead48c24"
    }
  },
  {
    "ts": null,
    "headline": "West Pharmaceutical Services (NYSE:WST) Exceeds Q1 Expectations, Stock Soars",
    "summary": "Healthcare products company West Pharmaceutical Services (NYSE:WST) announced better-than-expected revenue in Q1 CY2025, but sales were flat year on year at $698 million. The company’s full-year revenue guidance of $2.96 billion at the midpoint came in 2% above analysts’ estimates. Its non-GAAP profit of $1.45 per share was 18.1% above analysts’ consensus estimates.",
    "url": "https://finnhub.io/api/news?id=66cfb96dc922d06be1fab9c8e007ed3958ae076a62c043c3d23e6d84873d0d48",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745489273,
      "headline": "West Pharmaceutical Services (NYSE:WST) Exceeds Q1 Expectations, Stock Soars",
      "id": 134060044,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "WST",
      "source": "Yahoo",
      "summary": "Healthcare products company West Pharmaceutical Services (NYSE:WST) announced better-than-expected revenue in Q1 CY2025, but sales were flat year on year at $698 million. The company’s full-year revenue guidance of $2.96 billion at the midpoint came in 2% above analysts’ estimates. Its non-GAAP profit of $1.45 per share was 18.1% above analysts’ consensus estimates.",
      "url": "https://finnhub.io/api/news?id=66cfb96dc922d06be1fab9c8e007ed3958ae076a62c043c3d23e6d84873d0d48"
    }
  },
  {
    "ts": null,
    "headline": "West Announces First-Quarter 2025 Results, Increases Adjusted-Diluted EPS Guidance and Declares Third-Quarter 2025 Dividend",
    "summary": "West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the first-quarter 2025 and declared a third-quarter 2025 dividend.",
    "url": "https://finnhub.io/api/news?id=80a2449447944b4eb23df150f72de9b307017cecb204f74edbd7196036b64bde",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745488800,
      "headline": "West Announces First-Quarter 2025 Results, Increases Adjusted-Diluted EPS Guidance and Declares Third-Quarter 2025 Dividend",
      "id": 134060046,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "WST",
      "source": "Yahoo",
      "summary": "West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the first-quarter 2025 and declared a third-quarter 2025 dividend.",
      "url": "https://finnhub.io/api/news?id=80a2449447944b4eb23df150f72de9b307017cecb204f74edbd7196036b64bde"
    }
  },
  {
    "ts": null,
    "headline": "Artisan Mid Cap Fund Q1 2025 Commentary",
    "summary": "Artisan Mid Cap Fund Q1 2025 Commentary",
    "url": "https://finnhub.io/api/news?id=504522cd5e3fd13d5abfe4a862cbcd03ee0b8cbdc550a8e3deff36e3d3da48e7",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745457300,
      "headline": "Artisan Mid Cap Fund Q1 2025 Commentary",
      "id": 134051435,
      "image": "",
      "related": "WST",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=504522cd5e3fd13d5abfe4a862cbcd03ee0b8cbdc550a8e3deff36e3d3da48e7"
    }
  }
]